financetom
Business
financetom
/
Business
/
EXPLAINER-Is Tylenol safe to take during pregnancy?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EXPLAINER-Is Tylenol safe to take during pregnancy?
Sep 5, 2025 4:17 PM

Sept 5 (Reuters) - U.S. Health Secretary Robert F.

Kennedy Jr. plans to announce a link between autism and prenatal

exposure to the popular over-the-counter pain and fever medicine

Tylenol, sold generically as acetaminophen in the United States

and paracetamol in the UK, the Wall Street Journal reported on

Friday.

WHAT DOES THE RESEARCH SAY ON ACETAMINOPHEN USE DURING

PREGNANCY?

There is no firm evidence of a link between the use of

the drug and autism. Recent studies have yielded conflicting

conclusions on whether its use during pregnancy might

create risks for a developing fetus.

A 2024 study of nearly 2.5 million children in Sweden found

no causal link between in utero exposure to acetaminophen and

neurodevelopmental disorders like autism spectrum disorder or

attention deficit hyperactivity disorder.

A 2025 review of 46 earlier studies did suggest a link

between prenatal acetaminophen exposure and increased risks of

these conditions, but the researchers from the Icahn School of

Medicine at Mount Sinai, Harvard University and others said the

study does not prove the drug caused the outcomes. They advised

that pregnant women should continue to use acetaminophen as

needed, at the lowest possible dose and for the shortest

possible period.

Large 2025 studies from Europe and Japan have suggested that

what might appear to be small associations between prenatal

acetaminophen use and neurodevelopmental disorders might

actually be due to confounders, that is, other underlying

factors - such as environmental conditions, parents' health and

genetics, other medications the mothers may have been taking,

and illness.

WHAT ARE THE MEDICAL GUIDELINES FOR PREGNANT WOMEN?

Acetaminophen/paracetamol is the recommended first-line

medication for pain and fever during pregnancy in guidelines

from the American College of Obstetricians and Gynecologists,

Britain's Royal College of Obstetricians and Gynecologists, and

other medical organizations.

Use of ibuprofen, naproxen and other nonsteroidal

anti-inflammatory drugs in the third trimester can lead to birth

defects, both societies warn.

Pregnant women should talk to their doctor if they plan to

take any of these medications, ACOG advises.

WHAT ARE THE RISKS OF NOT REDUCING FEVER DURING PREGNANCY?

Untreated maternal fever and pain during fetal development

can increase the risks of birth defects such as heart

conditions, abdominal wall defects, and neural tube defects in

which the brain and spinal cord do not form properly. Untreated

pain and fever has also been linked with preterm birth, low

birth weight, and miscarriage.

In pregnant women, untreated fever and pain can cause high

blood pressure, dehydration, depression and anxiety, and other

health problems.

WHY IS THE SUBJECT IN FOCUS NOW?

Assertions of a potential link have been a focus of

lawsuits brought by parents and autism activists in the United

States against retailers, charging they failed to warn consumers

that Kenvue's ( KVUE ) Tylenol and its generic versions could

cause ADHD or autism.

In December 2023, a U.S. federal judge struck a blow to

hundreds of such lawsuits, barring expert witnesses from

testifying after finding they lacked scientific evidence for

their claims.

In August 2024, citing that ruling, the judge dismissed all

the cases in federal court. A U.S. appeals court is slated to

hear arguments next month in an appeal of that ruling, court

records show.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Capstone Secures $3.25 Million to Advance $15M Accretive Acquisition; Accelerates Progress Toward $100M Revenue Run-Rate
Capstone Secures $3.25 Million to Advance $15M Accretive Acquisition; Accelerates Progress Toward $100M Revenue Run-Rate
Oct 27, 2025
Follow-on draw affirms investor support for Capstone's growth strategy and reflects the company's disciplined approach to financing accretive acquisitions. NEW YORK, NY / ACCESS Newswire ( ACCS ) / October 27, 2025 / Capstone Holding Corp. ( CAPS ) , a national building products distribution platform, today announced a $3.25 million draw from its existing convertible note facility. This new...
DuBois Chemicals Acquires Broadmoor Products, Strengthening Its Position in Water Treatment
DuBois Chemicals Acquires Broadmoor Products, Strengthening Its Position in Water Treatment
Oct 27, 2025
CINCINNATI--(BUSINESS WIRE)-- DuBois Chemicals (“DuBois” or the “Company”), a leading full-service provider of customized specialty chemical solutions, today announced that it has acquired Broadmoor Products, Inc. (“Broadmoor Products” or “Broadmoor”), a leading provider of water treatment specialty chemistry products and services based in Grand Rapids, Michigan. Financial terms of the transaction were not disclosed. The acquisition represents another important step...
Market Chatter: Delta Air Lines CEO Flags Impacts of US Government Shutdown
Market Chatter: Delta Air Lines CEO Flags Impacts of US Government Shutdown
Oct 27, 2025
07:28 AM EDT, 10/27/2025 (MT Newswires) -- Delta Air Lines ( DAL ) Chief Executive Officer Ed Bastian said the US government shutdown is costing the company less than $1 million a day but is causing a shortage in airport security staff, Reuters reported Monday, citing an interview with the CEO. The staff shortage covers both security and air traffic...
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
Oct 27, 2025
Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. ( BWAY ) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced it has entered into two...
Copyright 2023-2026 - www.financetom.com All Rights Reserved